Epigenetic therapy and cisplatin chemoradiation in FIGO Stage IIIB cervical cancer.

MLA

Candelaria, M., et al. “Epigenetic Therapy and Cisplatin Chemoradiation in FIGO Stage IIIB Cervical Cancer.” European Journal of Gynaecological Oncology, vol. 31, no. 4, July 2010, pp. 386–91. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=53326755&authtype=sso&custid=ns315887.

APA

Candelaria, M., Cetina, L., Pérez-Cárdenas, E., de la Cruz-Hernández, E., González-Fierro, A., Trejo-Becerril, C., Taja-Chayeb, L., Chanona, J., Arias, D., & Dueñas-González, A. (2010). Epigenetic therapy and cisplatin chemoradiation in FIGO Stage IIIB cervical cancer. European Journal of Gynaecological Oncology, 31(4), 386–391.

Chicago

Candelaria, M., L. Cetina, E. Pérez-Cárdenas, E. de la Cruz-Hernández, A. González-Fierro, C. Trejo-Becerril, L. Taja-Chayeb, J. Chanona, D. Arias, and A. Dueñas-González. 2010. “Epigenetic Therapy and Cisplatin Chemoradiation in FIGO Stage IIIB Cervical Cancer.” European Journal of Gynaecological Oncology 31 (4): 386–91. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=53326755&authtype=sso&custid=ns315887.